3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Carcinoma, Renal Cell
64
Carcinoma, Hepatocellular
26
Prostatic Neoplasms
22
Neoplasm Metastasis
19
Neoplasms
18
Carcinoma, Non-Small-Cell Lung
16
Kidney Neoplasms
14
Osteosarcoma
9
Neuroendocrine Tumors
9
Colorectal Neoplasms
9
Carcinoma, Transitional Cell
9
Sarcoma
8
Carcinoma, Medullary
8
Urinary Bladder Neoplasms
7
Sarcoma, Ewing
7
Melanoma
7
Breast Neoplasms
7
Brain Neoplasms
7
Thyroid Neoplasms
6
Ovarian Neoplasms
6
Clear-cell metastatic renal cell carcinoma
6
Recurrence
5
Pancreatic Neoplasms
5
Lung Neoplasms
5
Carcinoma
5
Urethral Neoplasms
4
Triple Negative Breast Neoplasms
4
Multiple Myeloma
4
Thyroid Cancer, Papillary
3
Small Cell Lung Carcinoma
3
Interventions
Fentanyl
23
Analgesia
22
Morphine
19
Acupuncture Therapy
18
Zoledronic Acid
15
Oxycodone
14
Acetaminophen
14
Ketamine
13
Radiotherapy
12
Therapeutics
11
Methadone
11
Lidocaine
11
nabiximols
10
Ibandronic Acid
10
Hydromorphone
10
Bupivacaine
10
Surveys and Questionnaires
8
Ropivacaine
8
Psychiatric Rehabilitation
7
Early Intervention, Educational
7
Saline Solution
6
Music Therapy
6
Cryotherapy
6
Cryosurgery
6
Yoga
5
Water
5
Tapentadol
5
Pregabalin
5
Methods
5
Massage
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Pain
×
cabozantinib
×
Clear all
NCT01522443
2018-05-23
COMET-2
Exelixis
Phase 3
Terminated
119 enrolled
21 charts
NCT01605227
2018-03-14
COMET-1
Exelixis
Phase 3
Completed
1,028 enrolled
18 charts